文献速递中毒与环境急症消化、代谢与肾脏急症

接受院外纳洛酮治疗的疑似阿片类药物过量患者一年死亡率及相关因素

One-Year Mortality and Associated Factors in Patients Receiving Out-of-Hospital Naloxone for Presumed Opioid Overdose.
PubMed 文献 · Ann Emerg Med · 2020-01-23
一句话结论院外纳洛酮救治后临床改善的疑似阿片过量患者,1年死亡率是年龄匹配一般人群的13.2倍,属高危人群。

该研究为美国北卡罗来纳州7县2015年1月1日至2017年2月28日的区域回顾性队列研究,纳入接受院外纳洛酮的3085例疑似阿片过量患者,由院外提供者主观评估纳洛酮后是否改善。结果72.7%(2244例)改善,27.3%(841例)无改善;第365天改善亚组死亡12.0%(269例),无改善亚组死亡22.6%(190例),全人群死亡14.9%(459例)。改善者经年龄调整后1年死亡可能性是一般人群的13.2倍(95%CI 13.0–13.3)。高龄和黑人种族与1年死亡相关,性别和多次过量不相关。作者认为该高危人群值得公共卫生官员、政策制定者和医疗提供者关注以制定长期解决方案。

要点

  • 院外纳洛酮后临床改善的疑似阿片过量患者,1年死亡率为12.0%(269/2244),无改善者为22.6%(190/841)。
  • 改善者经年龄调整后1年死亡可能性是一般人群的13.2倍(95%CI 13.0–13.3)。
  • 全研究人群第365天死亡率为14.9%(459/3085)。
  • 高龄和黑人种族与1年死亡率相关,性别和多次过量与1年死亡率不相关。
  • 作者认为该人群为高危人群,值得公共卫生官员、政策制定者和医疗提供者关注以制定长期解决方案。

适用人群与场景

  • 2015年1月1日至2017年2月28日美国北卡罗来纳州7个县接受院外纳洛酮的疑似阿片类药物过量患者(n=3085)。

研究设计与关键结果

  • 研究类型:区域回顾性队列研究,纳入北卡罗来纳州7个县2015年1月1日至2017年2月28日院外记录中接受院外纳洛酮的患者(n=3085)。
  • 干预与对照:接受院外纳洛酮后由院外提供者主观评估是否改善,分为改善组(72.7%,n=2244)和无改善组(27.3%,n=841)。
  • 主要终点:第365天改善亚组死亡12.0%(n=269),无改善亚组死亡22.6%(n=190),全人群死亡14.9%(n=459)。
  • 改善者经年龄调整后1年死亡可能性是一般人群的13.2倍(95%CI 13.0–13.3)。
  • 高龄和黑人种族与1年死亡率相关,性别和多次过量与1年死亡率不相关。

证据类型、等级与局限

  • 证据类型:区域回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,院外纳洛酮救治后临床改善的疑似阿片过量患者1年死亡率是一般人群的13.2倍,该高危人群值得公共卫生官员、政策制定者和医疗提供者关注以制定长期解决方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Out-of-hospital naloxone has been championed as a lifesaving solution during the opioid epidemic. However, the long-term outcomes of out-of-hospital naloxone recipients are unknown. The objectives of this study are to describe the 1-year mortality of presumed opioid overdose victims identified by receiving out-of-hospital naloxone and to determine which patient factors are associated with subsequent mortality.

METHODS: This was a regional retrospective cohort study of out-of-hospital records from 7 North Carolina counties from January 1, 2015 to February 28, 2017. Patients who received out-of-hospital naloxone were included. Out-of-hospital providers subjectively assessed patients for improvement after administering naloxone. Naloxone recipients were cross-referenced with the North Carolina death index to examine mortality at days 0, 1, 30, and 365. Naloxone recipient mortality was compared with the age-adjusted, at-large population's mortality rate in 2017. Generalized estimating equations and Cox proportional hazards models were used to assess for mortality-associated factors.

RESULTS: Of 3,085 out-of-hospital naloxone encounters, 72.7% of patients (n=2,244) improved, whereas 27.3% (n=841) had no improvement with naloxone. At day 365, 12.0% (n=269) of the improved subgroup, 22.6% (n=190) of the no improvement subgroup, and 14.9% (n=459) of the whole population were dead. Naloxone recipients who improved were 13.2 times (95% confidence interval 13.0 to 13.3) more likely to be dead at 1 year than a member of the general populace after age adjusting of the at-large population to match this study population. Older age and being black were associated with 1-year mortality, whereas sex and multiple overdoses were not.

CONCLUSION: Opioid overdose identified by receiving out-of-hospital naloxone with clinical improvement carries a 13-fold increase in mortality compared to the general population. This suggests that this is a high-risk population that deserves attention from public health officials, policymakers, and health care providers in regard to the development of long-term solutions.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ashburn NP, Ryder CW, Angi RM, et al. One-Year Mortality and Associated Factors in Patients Receiving Out-of-Hospital Naloxone for Presumed Opioid Overdose. Ann Emerg Med. 2020. PMID: 31983499. doi:10.1016/j.annemergmed.2019.11.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。